These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15045038)

  • 1. The emerging technologies of neural xenografting and stem cell transplantation for treating neurodegenerative disorders.
    Harrower TP; Barker RA
    Drugs Today (Barc); 2004 Feb; 40(2):171-89. PubMed ID: 15045038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a future for neural transplantation?
    Harrower TP; Barker RA
    BioDrugs; 2004; 18(3):141-53. PubMed ID: 15161332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Fetal Neural Stem Cells for Neurodegenerative Disease Treatment.
    Ferrari D; Gelati M; Profico DC; Vescovi AL
    Results Probl Cell Differ; 2018; 66():307-329. PubMed ID: 30209666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging technologies of neural xenografting and stem cell transplantation for treating neurodegenerative disorders.
    Emerich DF
    Drugs Today (Barc); 2004 Mar; 40(3):271. PubMed ID: 15148535
    [No Abstract]   [Full Text] [Related]  

  • 5. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.
    Drouin-Ouellet J
    Neurodegener Dis Manag; 2014; 4(4):297-307. PubMed ID: 25313986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult human neural stem cells for autologous cell replacement therapies for neurodegenerative disorders.
    Galvin KA; Jones DG
    NeuroRehabilitation; 2006; 21(3):255-65. PubMed ID: 17167195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells for neurodegenerative disorders: where can we go from here?
    Le Belle JE; Svendsen CN
    BioDrugs; 2002; 16(6):389-401. PubMed ID: 12463763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of cell-based transplantation therapies for neurodegenerative disorders.
    Lazic SE; Barker RA
    J Hematother Stem Cell Res; 2003 Dec; 12(6):635-42. PubMed ID: 14977473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases.
    Lescaudron L; Boyer C; Bonnamain V; Fink KD; Lévêque X; Rossignol J; Nerrière-Daguin V; Malouet AC; Lelan F; Dey ND; Michel-Monigadon D; Lu M; Neveu I; von Hörsten S; Naveilhan P; Dunbar GL
    Methods Mol Biol; 2012; 879():147-64. PubMed ID: 22610559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organotypic cultures as tools for optimizing central nervous system cell therapies.
    Daviaud N; Garbayo E; Schiller PC; Perez-Pinzon M; Montero-Menei CN
    Exp Neurol; 2013 Oct; 248():429-40. PubMed ID: 23899655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular repair of the brain in Parkinson's disease--past, present and future.
    Sayles M; Jain M; Barker RA
    Transpl Immunol; 2004 Apr; 12(3-4):321-42. PubMed ID: 15157925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stem cell therapy for neurodegenerative disorders].
    Meyer M; Jensen P; Rasmussen JZ
    Ugeskr Laeger; 2010 Sep; 172(38):2604-7. PubMed ID: 20920404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [10 years of substitution therapy for neurodegenerative diseases using fetal neuron grafts: a positive outcome but with questions for the future].
    Peschanski M
    J Soc Biol; 2001; 195(1):51-5. PubMed ID: 11530501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine neural xenografts in the immunocompetent rat: immune response following grafting of expanded neural precursor cells.
    Armstrong RJ; Harrower TP; Hurelbrink CB; McLaughin M; Ratcliffe EL; Tyers P; Richards A; Dunnett SB; Rosser AE; Barker RA
    Neuroscience; 2001; 106(1):201-16. PubMed ID: 11564430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cells and neurodegeneration.
    Storch A; Schwarz J
    Curr Opin Investig Drugs; 2002 May; 3(5):774-81. PubMed ID: 12090552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease.
    Harrower TP; Tyers P; Hooks Y; Barker RA
    Exp Neurol; 2006 Jan; 197(1):56-69. PubMed ID: 16246328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS immunological modulation of neural graft rejection and survival.
    Borlongan CV; Stahl CE; Cameron DF; Saporta S; Freeman TB; Cahill DW; Sanberg PR
    Neurol Res; 1996 Aug; 18(4):297-304. PubMed ID: 8875445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell in neurodegenerative disorders; an emerging strategy.
    Ahani-Nahayati M; Shariati A; Mahmoodi M; Olegovna Zekiy A; Javidi K; Shamlou S; Mousakhani A; Zamani M; Hassanzadeh A
    Int J Dev Neurosci; 2021 Jun; 81(4):291-311. PubMed ID: 33650716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.